Kisspeptin and the HPG Axis: A 2026 Research Review

Kisspeptins are a family of RF-amide peptides encoded by the KISS1 gene and processed into several bioactive fragments, of which kisspeptin-10, kisspeptin-13, kisspeptin-14, and kisspeptin-54 are the most extensively studied. They signal through KISS1R (formerly GPR54), a class A G-protein-coupled receptor expressed in the hypothalamus, pituitary, and several peripheral tissues. This article summarizes the 2026 research literature at a laboratory-research level.

The scientific interest in kisspeptin stems from its role as an upstream regulator of gonadotropin-releasing hormone (GnRH) neurons in the hypothalamus, a position that makes it a master regulator of the hypothalamic-pituitary-gonadal (HPG) axis in preclinical models. Recent reviews indexed in PubMed and published in Frontiers in Endocrinology during the first half of 2026 have expanded characterization of the KNDy (kisspeptin/neurokinin B/dynorphin) neuron population and its role in pulsatile GnRH release.

From a receptor-pharmacology standpoint, KISS1R couples primarily to Gαq/11 with activation of phospholipase C, elevation of intracellular calcium, and downstream MAPK signaling. In-vitro characterization uses HEK293 or CHO cell lines stably expressing recombinant KISS1R with calcium mobilization or IP1 accumulation as primary readouts. Comparative structure-activity work across the kisspeptin fragment family has defined the C-terminal decapeptide as the minimum sequence required for receptor engagement.

For laboratory work with kisspeptin fragments, identity and purity documentation on the COA is essential. The RF-amide C-terminus is a defining structural feature and should be confirmed by mass spectrometry. Kisspeptin peptides are also susceptible to enzymatic degradation in aqueous solution, so aqueous stability data should be consulted and freeze-thaw cycles minimized for critical experiments.

Open questions in the 2026 literature include the peripheral roles of KISS1R signaling outside the reproductive axis, the pharmacology of engineered KISS1R agonists and antagonists, and the interaction of the kisspeptin system with other RF-amide peptide families. As always, primary literature review is the appropriate posture for a research laboratory.

All materials described are for in-vitro laboratory research only and are not for human or veterinary use.